Morgan Stanley Starts MiniMed Group (MMED) at Overweight
Morgan Stanley analyst Kallum Titchmarsh initiates coverage on MiniMed Group (NASDAQ: MMED) with a Overweight rating and a price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)